The Bioanalysis Industry Focus eBook, sponsored by SCIEX, explores the technologies transforming the way biological systems, biomarkers, and therapeutic compounds are measured and analyzed. Bringing together developments in biosensing, artificial intelligence (AI), advanced imaging, and mass spectrometry, this collection highlights the drive towards faster, more sensitive, and increasingly accessible bioanalysis.
Emerging sensing technologies are opening new possibilities for minimally invasive and continuous biological monitoring. Microneedle patches are enabling immune and cardiac biomarkers to be assessed through the skin, while bioresorbable sensors demonstrate the potential for longer-term monitoring of biochemical changes deep within tissue. Rapid diagnostic approaches are also advancing, with AI-assisted paper-based testing offering new ways to measure multiple biomarkers quickly and efficiently.
The eBook also examines innovations in neural and cancer bioanalysis, including sensors designed to overcome challenges associated with blue-light photoswitching and deep-learning holography for detecting elusive circulating tumor cells.
Alongside these emerging technologies, LC-MS/MS continues to play a critical role in quantitative bioanalysis. Featured content explores how nanoflow LC-MS/MS can enhance peptide quantitation sensitivity, how flexible LC-MS workflows are supporting evolving analytical requirements, and how minimal-preparation microsampling approaches can simplify pharmaceutical analysis.
Together, these developments demonstrate how advances in sensing, imaging, AI, and mass spectrometry are expanding the capabilities of modern bioanalysis, supporting more precise measurements and efficient analytical workflows across biomedical research, diagnostics, and pharmaceutical development.
About SCIEX
SCIEX mission is to deliver solutions for the precision detection and quantitation of molecules, empowering their customers to protect and advance the wellness and safety of all.
SCIEX has led the field of mass spectrometry for 50 years. From the moment it launched the first ever commercially successful triple quad in 1981, they have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.
Today, as part of the Danaher family of global life science and technology innovators, they continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. But they don’t just develop products. It is what they do together with their customers that sets them apart. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions. Decisions that positively impact lives.
They proudly stand behind our tagline: The Power of Precision.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.